AsOf

Recorded or changed on this day 2026-11-08

51–100 of 46,392 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 9,161,000,000 United States dollar
Abbott Laboratories cash and equivalents: 9,161,000,000 United States dollar, claim clm_14B748327E60 · ended · superseded by clm_34B14167D6F5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 52,666,000,000 United States dollar
Abbott Laboratories total assets: 52,666,000,000 United States dollar, claim clm_152F5F758C41 · ended · superseded by clm_FFC8F38C32CB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 67,173,000,000 United States dollar
Abbott Laboratories total assets: 67,173,000,000 United States dollar, claim clm_1558E1C3AC44 · ended · superseded by clm_6BF87C6DF992 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 6,335,000,000 United States dollar
Abbott Laboratories quarterly revenue: 6,335,000,000 United States dollar, claim clm_15BAEA02B893 · ended · superseded by clm_29C8A48CFFA6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,022,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,022,000,000 United States dollar, claim clm_166B1C725C2A · ended · superseded by clm_D60E926E5D8D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 6,087,581,000 United States dollar
Abbott Laboratories operating income: 6,087,581,000 United States dollar, claim clm_16CB3FB094C5 · ended · superseded by clm_E857AF3C6172 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 20,405,000,000 United States dollar
Abbott Laboratories revenue: 20,405,000,000 United States dollar, claim clm_16E555E53E25 · ended · superseded by clm_305771785CD8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,987,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,987,000,000 United States dollar, claim clm_16E584C7B895 · ended · superseded by clm_1FFA2B3FBAF9 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · total equity · 51,027,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 30,218,000,000 United States dollar
Abbott Laboratories total equity: 30,218,000,000 United States dollar, claim clm_178BA35B231F · ended · superseded by clm_1795E98E8729 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 30,578,000,000 United States dollar
Abbott Laboratories total equity: 30,578,000,000 United States dollar, claim clm_1795E98E8729 · ended · superseded by clm_2CE5107EE0B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,739,897,004 shares
Abbott Laboratories shares outstanding: 1,739,897,004 shares, claim clm_17BF8DBB11AD · ended · superseded by clm_B9E574E3CE32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,768,455,705 shares
Abbott Laboratories shares outstanding: 1,768,455,705 shares, claim clm_18993939AE37 · ended · superseded by clm_4CC142CFD436 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 897,000,000 United States dollar
Abbott Laboratories quarterly operating income: 897,000,000 United States dollar, claim clm_193539EFFD26 · ended · superseded by clm_47108AC0E4BE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 451,000,000 United States dollar
Abbott Laboratories quarterly operating income: 451,000,000 United States dollar, claim clm_1937F4CF953B · ended · superseded by clm_D93B193C9846 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,773,453,000 United States dollar
Abbott Laboratories quarterly operating income: 1,773,453,000 United States dollar, claim clm_19A69695BB00 · ended · superseded by clm_83E5B8F4B133 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 25,914,238,000 United States dollar
Abbott Laboratories revenue: 25,914,238,000 United States dollar, claim clm_1AE9E329ED59 · ended · superseded by clm_F17A9DA7A446 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,473,241,861 shares
Abbott Laboratories shares outstanding: 1,473,241,861 shares, claim clm_1B44F2DE8736 · ended · superseded by clm_E22E26C7A5C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,333,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,333,000,000 United States dollar, claim clm_1B83117F5484 · ended · superseded by clm_8064646C7C6E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 2,292,000,000 United States dollar
Abbott Laboratories quarterly net income: 2,292,000,000 United States dollar, claim clm_1C02430C4950 · ended · superseded by clm_C09A927BCCDA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,345,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,345,000,000 United States dollar, claim clm_1C0A2724D779 · ended · superseded by clm_2A39068943F3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 2,912,000,000 United States dollar
Abbott Laboratories quarterly operating income: 2,912,000,000 United States dollar, claim clm_1C12DA1AFF90 · ended · superseded by clm_6DD49D4EE601 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,573,391,467 shares
Abbott Laboratories shares outstanding: 1,573,391,467 shares, claim clm_1DFA7D7F2069 · ended · superseded by clm_9CD0F79343E3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,170,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,170,000,000 United States dollar, claim clm_1E113FF89F7B · ended · superseded by clm_4DDA3D71417E · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · quarterly research and development · 920,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 110,429,000,000 United States dollar
Abbott Laboratories total assets: 110,429,000,000 United States dollar, claim clm_1E6184001C61 · ended · superseded by clm_9F11A9C39281 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 5,723,000,000 United States dollar
Abbott Laboratories net income: 5,723,000,000 United States dollar, claim clm_1E79DAD01E1C · ended · superseded by clm_CF3E98D0B268 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 10,410,000,000 United States dollar
Abbott Laboratories quarterly revenue: 10,410,000,000 United States dollar, claim clm_1EE7A5C106ED · ended · superseded by clm_BDD05EB44D8B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,776,820,148 shares
Abbott Laboratories shares outstanding: 1,776,820,148 shares, claim clm_1F524FFD747D · ended · superseded by clm_08F7D872BEBD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,334,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,334,000,000 United States dollar, claim clm_1FC299F54EDD · ended · superseded by clm_FA8D28D995F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 7,558,000,000 United States dollar
Abbott Laboratories cash and equivalents: 7,558,000,000 United States dollar, claim clm_1FFA2B3FBAF9 · ended · superseded by clm_BE323442D575 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,472,309,523 shares
Abbott Laboratories shares outstanding: 1,472,309,523 shares, claim clm_20D5B4C10A23 · ended · superseded by clm_D91F2017CC04 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · CFO · Philip P. Boudreau
Abbott Laboratories CFO: Philip P. Boudreau, claim clm_216BEF8E327D · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 83,999,000,000 United States dollar
Abbott Laboratories total assets: 83,999,000,000 United States dollar, claim clm_217C000CA5A2 · ended · superseded by clm_87D9C9A99CA7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 4,897,000,000 United States dollar
Abbott Laboratories quarterly revenue: 4,897,000,000 United States dollar, claim clm_217D209218A4 · ended · superseded by clm_1E113FF89F7B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,575,722,000 United States dollar
Abbott Laboratories quarterly operating income: 1,575,722,000 United States dollar, claim clm_21EACF91396A · ended · superseded by clm_49FD4920B6B3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,756,470,269 shares
Abbott Laboratories shares outstanding: 1,756,470,269 shares, claim clm_2216B46B8180 · ended · superseded by clm_24ACD32E0696 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 52,130,000,000 United States dollar
Abbott Laboratories total equity: 52,130,000,000 United States dollar, claim clm_233C6F73AC72 · ended · superseded by clm_3A1641DA4DD9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 672,000,000 United States dollar
Abbott Laboratories quarterly research and development: 672,000,000 United States dollar, claim clm_235E5A9BD334 · ended · superseded by clm_C910D6802F6E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 21,211,000,000 United States dollar
Abbott Laboratories total equity: 21,211,000,000 United States dollar, claim clm_2369723DE4DA · ended · superseded by clm_9E0E24B3E644 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,392,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,392,000,000 United States dollar, claim clm_23A44C31565F · ended · superseded by clm_48E46D6ED9A6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,859,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,859,000,000 United States dollar, claim clm_23C6088E7F70 · ended · superseded by clm_75BE91C87765 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · quarterly operating income · 1,358,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 26,720,961,000 United States dollar
Abbott Laboratories total equity: 26,720,961,000 United States dollar, claim clm_24230E6F3612 · ended · superseded by clm_CEDF1D0510CD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 7,675,000,000 United States dollar
Abbott Laboratories cash and equivalents: 7,675,000,000 United States dollar, claim clm_2441D3B433A5 · ended · superseded by clm_B9EFB00ADC3F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,764,181,262 shares
Abbott Laboratories shares outstanding: 1,764,181,262 shares, claim clm_24ACD32E0696 · ended · superseded by clm_8048076BF037 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 697,000,000 United States dollar
Abbott Laboratories quarterly research and development: 697,000,000 United States dollar, claim clm_24C066E1F3E1 · ended · superseded by clm_D0D6418B59F7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 654,000,000 United States dollar
Abbott Laboratories quarterly research and development: 654,000,000 United States dollar, claim clm_258F725B9941 · ended · superseded by clm_F2D32AEB2B4A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 25,171,000,000 United States dollar
Abbott Laboratories total equity: 25,171,000,000 United States dollar, claim clm_25A96CED8FE3 · ended · superseded by clm_C84177F7FADC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 928,000,000 United States dollar
Abbott Laboratories quarterly net income: 928,000,000 United States dollar, claim clm_260A61887540 · ended · superseded by clm_0E055280C61A · 1 source (1 primary) · conf 0.95

What the statuses mean